Summary
Analog Devices Inc. (ADI) reported for the fiscal year ending October 30, 2009, a period significantly impacted by the global economic downturn. Revenue declined by 22% year-over-year to $2.01 billion, reflecting cautious customer spending across key markets like Industrial, Communications, and Consumer. Despite the revenue drop and a 52% decrease in diluted EPS from continuing operations to $0.85, the company maintained a solid gross margin of 55.5% and generated $432.1 million in cash flow from operations. ADI ended the fiscal year with a robust cash position of $1.816 billion, demonstrating resilience amidst challenging economic conditions. The company also continued its strategic focus on innovation, investing substantially in R&D, and initiated cost-reduction measures including facility consolidation.
Financial Highlights
33 data points| Revenue | $2.01B |
| Cost of Revenue | $896.27M |
| Gross Profit | $1.12B |
| R&D Expenses | $446.98M |
| SG&A Expenses | $333.18M |
| Operating Expenses | $833.82M |
| Operating Income | $284.82M |
| Interest Expense | $4.09M |
| Net Income | $247.77M |
| EPS (Basic) | $0.85 |
| EPS (Diluted) | $0.85 |
| Shares Outstanding (Basic) | 291.38M |
| Shares Outstanding (Diluted) | 292.70M |
Key Highlights
- 1Revenue decreased by 22% to $2.01 billion in fiscal year 2009 compared to fiscal year 2008, primarily due to the global economic downturn impacting customer spending.
- 2Diluted EPS from continuing operations fell by 52% to $0.85 in fiscal year 2009, reflecting the adverse economic conditions.
- 3Gross margin remained strong at 55.5% in fiscal year 2009, though down from 61.1% in fiscal year 2008, impacted by lower sales and utilization variances.
- 4Generated $432.1 million in cash flow from operations, indicating operational efficiency and strong cash generation capabilities.
- 5Ended the fiscal year with $1.816 billion in cash, cash equivalents, and short-term investments, providing significant liquidity.
- 6The Industrial segment remained the largest revenue contributor at 52% of total revenue, demonstrating its importance to ADI's business.
- 7The company actively managed costs, including a decrease in R&D expenses by 16% and SMG&A expenses by 20% year-over-year, and initiated special charges related to facility consolidations and workforce reductions.